Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Mirati Therapeutics Inc

MYG:CN

Ticker Delisted

Company Profile for Mirati Therapeutics Inc (MYG)

Mirati Therapeutics, Inc. is a targeted oncology company developing a pipeline of therapeutics for precisely defined patient populations. The Mirati team is using a blueprint proven by their prior work for developing potential breakthrough therapies with accelerated development paths.

Contact Information

Mirati Therapeutics Inc

9363 Towne Centre Drive
Suite 200
San Diego, CA 92121
United States
Phone: 858-535-2075

Key Executives for Mirati Therapeutics Inc (MYG)

Charles M BaumPresident/CEOMark J GergenExec VP/COO
Isan ChenExec VP/Chief Medical OfcrJames ChristensenSenior VP/Chief Scientfic Ofcr
Jamie A DonadioVP:Finance

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil